home-plant-dark_hero-headerhome-plant-light_hero-header

Lighting the way to your finished ATMP

Top-tier manufacturing & Europe-wide distribution

Along with our expertise in the design and development of advanced therapies, we also support you with top-tier infrastructure and capabilities for producing ATMPs under the highest standards of quality and regulatory compliance. At Ideeea Therapeutics we have established a strategic alliance with Cellab CDMO for the manufacturing of ATMPs.

Choose Ideeea Therapeutics as your trusted partner for your cell and gene therapy development and manufacturing. Contact us today to learn more about our services and how we can help bring your therapy to market faster.

ideeea-agacell_web_icon_XL_GMP
plant petri aabb-lightplant petri aabb-dark

Discover our state-of-the-art facilities

Cellab CDMO is both GMP compliant and AABB accredited. We have the capacity and expertise to undertake every single stage in the manufacturing process of an ATMP product.

cellab_logo

Collection of ASC (Adipose stem cells)
Enrichment and depletion: equipped with a CliniMACS system)
Activation, gene delivery and expansion: 700+ billion cells maximum throughput
Cryopreservation: 40.000+ units
Collection of ASC (Adipose stem cells)
Enrichment and depletion: equipped with a CliniMACS system)
Activation, gene delivery and expansion: 700+ billion cells maximum throughput
Cryopreservation: 40.000+ units

Strategic location in Andorra

EU batch release, delivering across Europe

ideeea-agacell_web_icon_XL_EU
ideeea-agacell-tx_map

Our facilities are fully equipped with cutting-edge technology for GMP manufacturing of allogeneic and autologous cell therapies

ideeea-agacell_web_icon_XL_microscope
plant-ind to market-lightplant-ind to market-dark

Lighting the way from your IND to the market

Streamline your journey from your IND (Investigational New Drug) to the market with a seamless CMC (Chemistry, Manufacturing and Controls) strategy, guided by a team with extensive expertise in advancing cell and gene therapies from early-stage discovery to successful commercialization. Our cell and gene therapy expertise covers a wide range of modalities, including autologous and allogeneic T-cell therapies (CAR-T, TCR, Treg), NK cells, iPSCs, MSCs, Extracellular Vesicles & Non-Cellular based therapies, and more.

With expertise in cell culture and both viral and non-viral genetic modification, we support a wide range of cell types, ensuring high-quality production for cell and gene therapy applications.

Our most relevant expertise includes:


Pluripotent and Stem Cells


Immune and Blood-Derived Cells


Extracellular Vesicles & Non-Cellular Products




Discover our scope of services at Cellab CDMO

ideeea-agacell_web_icon_XL_handshake

Process Development

  • GMP Bioprocess Design
  • Scale-up
  • Cryopreservation strategy
  • Potency assays
  • Donor or tissue selection
  • Stability testing

GMP & GMP-Like Manufacturing

  • Cell separation
  • Gene editing
  • Cell expansion and conditioning
  • Fill and Finish
  • Cryopreservation and cell banking

Quality Control

  • Mycoplasma
  • Morphology
  • Cell count
  • Viability
  • Identity
  • Purity
  • Sterility

Logistics

  • EU Batch Release
  • GMP Bank
  • Custom Clearance Service
  • Transport Validation
  • Shipping Worldwide



Subscribe to our newsletter and enlighten your inbox with our latest news!